Cystic fibrosis-related diabetes testing in Massa Martana
Find health labs to test for Cystic fibrosis-related diabetes in Massa Martana and compare all offers by prices and services.
test prediabete e diabete con autoprelievo by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€35.00
€33.25 with our promocode
See Details
Diabetes Test by Premiata Farmacia Amici
Piazza Giuseppe Garibaldi, 06049 Spoleto PG, Italia
11.3 km
Diabetes Test by Farmacia Conti Dott.Valentino
Via Gabelletta, 147B, 05100 Terni TR, Italia
16.1 km
Diabetes Test by La Quintana - Centro Medico
Via Giovanni Polanga, 1, 06034 Foligno PG, Italia
15.4 km
Hemoglobin Test by Salvati Diagnostica - Poliambulatorio e Laboratorio Analisi
Piazza del Mercato, 61, 05100 Terni TR, Italia
16.1 km
Hemoglobin Test by Salvati Diagnostica - Poliambulatorio e Laboratorio Analisi
Via Tuderte, 426, 05035 Narni TR, Italia
17.7 km
Diabetes Test by Laboratorio Alexander Fleming Snc
Via San Michele Arcangelo, 8/M, 06083 Bastia Umbra PG, Italia
20.1 km
Diabetes Test by "Clinilab" Laboratorio Analisi Cliniche
Via Alessandro Manzoni, 418, 06135 Perugia PG, Italia
23.9 km
Verified
A Diabetes Test costs €44.00
See Details
Diabetes Test by Delta Implants
Via Pietro Cestellini, 11, 06135 Perugia PG, Italia
23.9 km
Unverified
A Diabetes Test costs €30.00
See Details
Diabetes Test by Farmacia Genovesi
Via Roma, 1, 05030 Otricoli TR, Italia
24.4 km
Diabetes Test by PROTOS Centro Diagnostico
Via del Discobolo, 14, 06132 Perugia PG, Italia
23.9 km
Unverified
A Diabetes Test costs €30.00
See Details
Cystic fibrosis-related diabetes - symptoms and how to test
Diabetes mellitus is a common disease; however, cystic fibrosis can cause a unique type of disease called cystic fibrosis-related diabetes (CFRD). This type of diabetes mellitus is different from both type 1, and type 2 diabetes yet has specific characteristics. The primary reason is insulin insufficiency due to islet cell death. Adults and adolescents with cystic fibrosis often develop diabetes because of their condition. Moreover, a third of CF patients aged 16 and up are receiving therapy for CFRD, according to 2018 data from the UK CF Registry. Among children aged 10 to 15, just 11% are receiving medication. There is evidence that early treatment of diabetes improves prognosis, and the fact that diabetes and poor glucose tolerance are both associated with worse health outcomes in people with CF emphasises the necessity of an early diagnosis.
